Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virologic Outcomes of Changing Enfuvirtide to Raltegravir in HIV-1 Patients Well Controlled on an Enfuvirtide Based Regimen

NCT00529243 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT00529243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00529243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virologic Outcomes of Changing Enfuvirtide to Raltegravir in HIV-1 Patients Well Controlled on an Enfuvirtide Based Regimen
Lead sponsor
Kaiser Permanente
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
September 30, 2009
Enrollment
52 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections